SOLOSEC is a Oral Granule in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Secnidazole.
| Product ID | 27437-051_2d4f4392-eef9-470e-83a0-6fe7a695ecd9 |
| NDC | 27437-051 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SOLOSEC |
| Generic Name | Secnidazole |
| Dosage Form | Granule |
| Route of Administration | ORAL |
| Marketing Start Date | 2017-10-30 |
| Marketing Category | NDA / NDA |
| Application Number | NDA209363 |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Substance Name | SECNIDAZOLE |
| Active Ingredient Strength | 2 g/4.8g |
| Pharm Classes | Nitroimidazole Antimicrobial [EPC],Nitroimidazoles [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2017-10-30 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA209363 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-03-19 |
| Marketing Category | NDA |
| Application Number | NDA209363 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2017-10-30 |
| Ingredient | Strength |
|---|---|
| SECNIDAZOLE | 2 g/4.8g |
| SPL SET ID: | 551e43d5-f700-4d6e-8029-026f8a8932ff |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 27437-051 | SOLOSEC | secnidazole |
| 64811-401 | Solosec | SECNIDAZOLE |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SOLOSEC 86696432 5498160 Live/Registered |
Symbiomix Therapeutics, LLC 2015-07-17 |